abNEX™ MTB Kit

Targeted NGS panel page for abNEX MTB Kit covering 34 drug-resistance genes and 48 co-infection pathogens.

Targeted MTB NGS

abNEX MTB Kit

Targeted NGS - abNEX

Targeted NGS panel page for abNEX MTB Kit covering 34 drug-resistance genes and 48 co-infection pathogens.

34 DR genes48 co-infection pathogensMTBTargeted NGS

Targets Mycobacterium tuberculosis workflow needs with 34 drug-resistance genes.
Adds co-infection context through 48 co-infection pathogens described in the product portfolio.
Supports laboratories building MTB drug-resistance and co-infection sequencing services.
Can be discussed with TB-focused DeepChek assays depending on platform, throughput, and reporting goals.

DR genes34

Co-infection pathogens48

Disease areaTuberculosis

Technology areaTargeted NGS

Product / workflow	Positioning
abNEX MTB Kit	34 DR genes, 48 co-infection pathogens
Related assays	DeepChek TB Assays, HybridChek TB Assays

Use this page for MTB sequencing requests where drug-resistance genes and co-infection pathogen coverage are both part of the discussion.

Request Information

Genient can support assay selection, platform fit, validation planning, training, reporting workflow and downstream bioinformatics discussions.